Seroprevalence of measles antibodies among high-risk healthcare workers in Auckland, New Zealand: Additional justification for assumption of age-determined immunity based on local data

Infection Control and Hospital Epidemiology

Volumn 31, Issue 10, 2010, Pages 1082-1084

  Williamson, Deborah ^a   Freeman, Joshua ^a   Austin, Paul ^a   Allum, Caroline ^b   Roberts, Sally ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MEASLES VACCINE;

ARTICLE; CLINICAL PRACTICE; EPIDEMIC; HEALTH CARE PERSONNEL; HIGH RISK POPULATION; HUMAN; IMMUNITY; INFECTION RISK; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; NEW ZEALAND; OCCUPATIONAL EXPOSURE; PRACTICE GUIDELINE; PREEMPLOYMENT MEDICAL EXAMINATION; SCREENING; SEROPREVALENCE; VIRUS INFECTION;

ADULT; AGING; ANTIBODIES, VIRAL; HEALTH PERSONNEL; HUMANS; IMMUNITY; IMMUNOGLOBULIN G; MASS SCREENING; MEASLES; MEASLES VACCINE; MEASLES VIRUS; MIDDLE AGED; NEW ZEALAND; RISK ASSESSMENT; SEROEPIDEMIOLOGIC STUDIES; VACCINATION; YOUNG ADULT;

EID: 77957861437     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/656379     Document Type: Article

References (12)

1. van den Hof S, Meffre CM, Conyn-van Spaendonck MA, Woonink F, de Melker HE, van Binnendijk RS. Measles outbreak in a community with very low vaccine coverage, the Netherlands. Emerg Infect Dis 2001;7(suppl 3):593-597.
2. Permar SR, Griffin DE, Letvin NL. Immune containment and consequences of measles virus infection in healthy and immunocompromised individuals. Clin Vaccine Immunol 2006;13:437-443.
3. Immunization of healthcare workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 1997;46(RR-18):1-42.
4. New Zealand Public Health Surveillance Report. http://www.surv.esr.cri. nz/PDF-surveillance/NZPHSR/2009/NZPHSR2009Dec.pdf. Published December 2009. Accessed August 19, 2010.
5. New Zealand Ministry of Health. Immunisation Handbook 2006. Wellington, New Zealand: Ministry of Health, 2006.
6. Uckay I, Hugonnet S, Kaiser L, Sax H, Pittet D. Age limit does not replace serologic testing for determination of immune status for measles. Infect Control Hosp Epidemiol 2007;28(9):1117-1120.
7. New Zealand Ministry of Health. National Serosurvey of Vaccine Preventable Diseases: Report to the Ministry of Health 2009. Wellington, New Zealand: Ministry of Health, 2009.
8. Asari S, Deguchi M, Tahara K, et al. Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan. Am J Infect Control 2003; 31:157-162.
9. Seo SK, Malak SF, Lim S, Eagan J, Sepkowitz KA. Prevalence of measles antibody among young adult healthcare workers in a cancer hospital: 1980s versus 1998-1999. Infect Control Hosp Epidemiol 2002;23:276-278.
10. Almuneef MA, Memish ZA, Balkhy HH. Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia. Infect Control Hosp Epidemiol 2006;27:1178-1183.
11. Tischer A, Gassner M, Richard J-L, Suter-Riniker F, Mankertz A. Vaccinated students with negative enzyme immunoassay results show positive measles virus-specific antibody levels by immunofluorescence and plaque neutralisation tests. J Clin Virol 2007;38: 204-209.
12. Stewart AM. Mandatory vaccination of health care workers. N Engl J Med 2009;361(21):2015-2017.